Compare FISN & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FISN | CDXS |
|---|---|---|
| Founded | 2023 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Major Chemicals |
| Sector | Utilities | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 142.0M | 154.4M |
| IPO Year | 2025 | 2008 |
| Metric | FISN | CDXS |
|---|---|---|
| Price | $3.36 | $1.30 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $18.60 | $6.14 |
| AVG Volume (30 Days) | 533.1K | ★ 784.4K |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 98.25 | 43.82 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $138,590,000.00 |
| Revenue This Year | N/A | $4.97 |
| Revenue Next Year | N/A | $18.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 32.30 |
| 52 Week Low | $2.10 | $0.96 |
| 52 Week High | $15.50 | $2.98 |
| Indicator | FISN | CDXS |
|---|---|---|
| Relative Strength Index (RSI) | 37.26 | 45.53 |
| Support Level | N/A | $1.25 |
| Resistance Level | $7.45 | $2.70 |
| Average True Range (ATR) | 0.43 | 0.08 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 42.40 | 38.64 |
Deep Fission Inc is a nuclear energy technology company developing a small modular reactor based on established pressurized water reactor technology, with novel emplacement in deep boreholes approximately one mile below the Earth's surface. Its reactor, which is referred to as the Gravity Reactor, will leverage subsurface conditions to support key containment and operating functions, including the use of hydrostatic pressure from a water column within the borehole to support reactor operating pressure and cooling, and the surrounding geological formation to provide structural confinement and shielding. The group's focus is within the United States, where electricity demand growth, expanding digital infrastructure, and evolving energy policy.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.